-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hip-fracture-pain.ppt
May 01, 2011 - AHRQ Publication No. 11-EHC022-EF
http://effectivehealthcare.ahrq.gov/hippain.cfm
Overall, adverse event … Adverse Events Influenced by Pain Management Interventions
Overall, adverse event rates were similar
-
effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain.ppt
May 01, 2011 - AHRQ Publication No. 11-EHC022-EF
http://effectivehealthcare.ahrq.gov/hippain.cfm
Overall, adverse event … Adverse Events Influenced by Pain Management Interventions
Overall, adverse event rates were similar
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/standardized-library-depression-white-paper.pdf
May 01, 2020 - Research White Paper: Standardized Library of Depression Outcome Measures
Research White Paper
Standardized Library of Depression Outcome
Measures
Research White Paper
Standardized Library of Depression Outcome
Measures
Prepared for:
Agency for Healthcare Research and Qual…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/standardized-library-depression-white-paper.pdf
May 01, 2020 - Research White Paper: Standardized Library of Depression Outcome Measures
Research White Paper
Standardized Library of Depression Outcome
Measures
Research White Paper
Standardized Library of Depression Outcome
Measures
Prepared for:
Agency for Healthcare Research and Qual…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tethered-spinal-cord-protocol.pdf
July 19, 2023 - who experience
retethering after spinal detethering surgery
Tethering of the spine as
an adverse event … KQ 1: no comparator
For KQ 2-4, Studies
without comparator except
for studies for an adverse
event … , an obvious effectiveness indicator is
missing) or inadequately reported (e.g., anecdotal adverse event
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-220-disposition-comments-analgesics-prehospital-setting.pdf
September 03, 2019 - In
the event that a study did not use inclusion
criteria of moderate or severe pain and did not
report … Peer reviewer
#4
General Does the “any adverse event” category include
events other than hypotension … “Any adverse event” was what the individual
studies would report as the number of subjects
who experienced … an adverse event in the trial,
regardless of what that adverse event was. … The
outcomes are defined (including “any adverse
event” in the methods chapter).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-disposition-comments-analgesics-prehospital-setting.pdf
September 03, 2019 - In
the event that a study did not use inclusion
criteria of moderate or severe pain and did not
report … Peer reviewer
#4
General Does the “any adverse event” category include
events other than hypotension … “Any adverse event” was what the individual
studies would report as the number of subjects
who experienced … an adverse event in the trial,
regardless of what that adverse event was. … The
outcomes are defined (including “any adverse
event” in the methods chapter).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - (elective) as a result of an adverse event … undertaken at any time post-
transplant and is usually a result of an unacceptable CNI related adverse event … Strategy Definition Timing
Minimization Lower dosage of CNI Planned de novo, or result of adverse event … of CNI dose until eliminated and
replaced with other immunosuppressant
Usually result of adverse event … until eliminated; may
be replaced with other immunosuppressant
Planned de novo or result of adverse event
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
October 01, 2010 - compare studies in the first 4 yrs and last 4 yrs
Newer studies appear to have reported lower adverse event … Most studies used multivariate logistic regression as opposed to time
to event analysis in drawing their … Most studies reported hazard
ratios, implying at least a time to event analysis, though granted studies … subjects observed with a primary AE experienced either
improvement or complete resolution of the adverse event … clinical trials
becomes standardized and that studies follow frequent asymptomatic
monitoring (e.g., event
-
effectivehealthcare.ahrq.gov/products/dietary-supplements/research
April 30, 2012 - Current Page Topic Timeline Apr. 1, 2009 Topic Suggestion Dec. 21, 2010 Research Protocol Apr. 30, 2012 Systematic Review Jul. 3, 2013 Surveillance Report Dietary Supplements in Adults Taking Cardiovascular Drugs
Systematic Review Archived April 30, 2012 Web Version [NLM Site] Download Main Document PDF 6.8 MB
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
November 15, 2013 - Topic 0438 Risk stratification and CAD NSD FINAL_SJ-2
Risk stratification and CAD
Nomination Summary Document
Results of Topic Selection Process & Next Ste…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
June 01, 2021 - Comparative Effectiveness Review
Number 242
Radiation Therapy for Brain Metastases
Evidence Summary
Main Points
• We identified a large number of relevant radiation therapy studies (97 studies
reported in 190 publications). Studies assessed whole brain radiation therapy
(WBRT) and stereotacti…
-
effectivehealthcare.ahrq.gov/products/autism-update/clinician
September 23, 2014 - Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorder
Clinician Summary Archived September 23, 2014 Download Main Document PDF 211.1 KB
Archived: This summary is based on a report that is greater than 3 years old. Findings should not be considered current.
Key Clinical Iss…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
September 01, 2014 - Developmental Delays
Autism Spectrum Disorder
Clinician Research Summary
Comparative Effectiveness of Therapies for Children With Autism
Spectrum Disorder
Key Clinical Issue
What evidence is available regarding the effectiveness, benefits, and harms of therapies used to address the core and
associated symptoms seen…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-key-question.pdf
September 18, 2023 - Key Question Tumor Cell-free DNA for Cancer Screening
1
Key Question Tumor Cell-free DNA for Cancer Screening
Background
Multicancer early detection (MCED) tests have an intriguing potential for population cancer
screening.1, 2 Like many technological advancements, the development of MCEDs was born out
o…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
October 01, 2014 - However, we included studies that aggregated adverse event data across patients with various
conditions … , akathisia, sedation, and abdominal pain
(Stocks et al., 2012).
25 studies compared the adverse event … exception to
this trend was a significant effect in favor of
aripiprazole for prolactin related adverse event … Patients tapering off the
drug had significantly longer time to “mood event”
than those on placebo. … findings related to
adverse events for
molindone
hydrochloride.
25 studies compared the adverse
event
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - examined the relative efficacy of
these interventions in specific patient subgroups as well
as adverse event … To evaluate adverse events
and complications (Key Question 3), we assessed the
rate of each adverse event
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
January 01, 2022 - 2
Background and Purpose
PTSD is a disorder that results from being exposed to a traumatic event
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioids-oa-protocol.pdf
June 29, 2019 - We will extract all eligible specific outcome categories (e.g., opioid misuse, fall,
cardiovascular event
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - research expert
noted concerns over renal adverse events, which could require additional adverse event